Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RGLS Stock Forecast, Price Targets, Chart, Dividends & Analysis

Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.63
 
USD
  
-0.04
  
(-2.40%)
Previous close: 1.67  Open: 1.66  Bid: 1.48  Ask: 1.76
52 week range    
1.08   
   3.79
Mkt Cap: 103 M  Avg Vol (90 Days): 372,868
Peers   
SNY / 
ALNY / 
GSK / 
BIIB / 
BMY / 
SGMO / 
Last updated: Friday 4th October 2024

Stock Rankings

52
MarketXLS Rank
80
Value
38
Technical
39
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

35 B-77269.53

AZN

BIIB

28 B24.37184.78

BMY

0.0471107 B-1754.2

GSK

SGMO

0 B-10.7925

SNY

Financials

RGLS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-100000.0-100000.0-100000.0-100000.0-100000.0-100000.0100000.0100000.0100000.0100000.0
Basic EPS from continuing operations-4.5-3.21.861.58
Basic EPS total-4.5-3.21.86-1.58
Basic weighted shares outstanding4,409 M5 M5 M8 M871856.02 M3 M9 M15 M19 M
Depreciation-1 M-2 M-2 M-3 M-2 M-931000.0500000.0459000.0
Depreciation unreconciled-1 M
DepreciationAndAmortization-1 M-2 M-2 M-3 M-2 M-931000.0500000.0459000.0
Diluted EPS total-12.9-10.8-15.5-9.6-55.9-10.8-4.5-3.21.86-1.58
Diluted normalized net income/share-3.21.861.58
Diluted weighted shares outstanding4 M5 M5 M7 M871359.02 M3 M9 M15 M19 M
GainOnSaleOfPPE-2 M
GainOnSaleOfSecurity3000.0-2 M
GeneralAndAdministrativeExpense12 M19 M18 M17 M13 M11 M9 M10 M10 M10 M
Gross operating profit8 M21 M1 M72000.072000.07 M10 M
Income before tax-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M-30 M
Income restructuring and M&A-4 M
Income taxes1000.0-18000.0-4000.0-197000.062000.01000.0-927000.01000.01000.01000.0
Interest income388000.0855000.0844000.0752000.0459000.0374000.0233000.0864000.0605000.02 M
InterestExpenseNonOperating39000.052000.01 M3 M2 M2 M2 M855000.0688000.0604000.0
MiscOtherSpecialCharges-12 M-2 M
Net income from total operations-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M-30 M
NetIncomeCommonStockholders-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M-30 M
NetIncomeContinuousOperations-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M-30 M
NetNonOperatingInterestIncomeExpense349000.0803000.0-338000.0-2 M-2 M-2 M-2 M9000.0-83000.01 M
Normalized income-22 M
Operating income-45 M-55 M-82 M-70 M-47 M-17 M-14 M-28 M-28 M-31 M
Operating income before depreciation (EBITDA)-54 M-53 M-78 M-67 M-44 M-16 M-13 M-26 M-28 M-29 M
OperatingExpense-53 M-76 M-83 M-70 M-47 M-24 M24 M28 M28 M31 M
Other income net12 M2 M2 M2 M
OtherGandA12 M19 M18 M17 M13 M11 M9 M10 M10 M10 M
OtherOperatingExpenses-53 M-76 M-83 M-70 M-47 M-24 M-1 M-188000.0-295000.0-449000.0
RentAndLandingFees12 M19 M18 M17 M13 M11 M
Research & development expense41 M56 M64 M53 M34 M12 M15 M18 M18 M21 M
ResearchExpense41 M56 M64 M53 M34 M12 M15 M18 M18 M21 M
RestructringAndMnAIncome-4 M
Revenue per share-100000.0-100000.0-100000.0-100000.0-100000.0-182000.0278000.0129000.0100000.0100000.0
SalariesAndWages-7 M-15 M-13 M-8 M-5 M-2 M
Selling Gen & administrative expense12 M19 M18 M17 M13 M11 M9 M10 M10 M10 M
Special income/charges4 M
Total Income available for interest expense (EBIT)-57 M-56 M-81 M-69 M-46 M-16 M-14 M-27 M-28 M-29 M
Total common shares outstanding420972.0439206.0441103.0866325.01 M2 M7 M15 M17 M65 M
Total net income-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M-30 M
Total ordinary shares65 M65 M65 M65 M65 M65 M65 M65 M65 M65 M
Total revenues8 M21 M1 M72000.072000.07 M10 M
TotalExpenses-53 M-76 M-83 M-70 M-47 M-24 M24 M28 M28 M31 M
TotalRevenue8 M21 M1 M72000.072000.07 M10 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University